Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneSystems was a French biotechnology company specializing in the development of rapid molecular diagnostic systems for pathogen detection. The company's core technology, the GeneDisc platform, utilizes real-time PCR to provide fast and accurate results for environmental monitoring and food safety applications. By automating the detection process, GeneSystems enabled the identification of pathogens like Legionella, E. coli, and Listeria in hours rather than the days required by traditional culture methods. The company was acquired by Pall Corporation in 2008 to enhance its rapid microbiology portfolio for industrial and life sciences customers. Today, the GeneSystems technology remains a key component of Pall's environmental and food safety testing solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneSystems.